TENX   $4.93  1.65% Market Closed

Tenax Therapeutics Inc
Total Cash 9.38M
totalCashPerShare 2.753
EBITDA -13.03M
Total Debt 278.80K
quickRatio 5.391
currentRatio 6.098
Total Revenue
debtToEquity 3.141
Revenue/Share
ROA -0.66086
ROE -1.1378601
grossProfits
freeCashflow -7.55M
operatingCashflow -11.45M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 6.44M
forwardPE -0.8839459
floatShares 2.64M
sharesOutstanding 3.41M
sharesShort 21.03K
sharesShortPriorMonth 50.31K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.47%
Short Ratio help_outline 0.68%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 4.533
Price To Book help_outline 1.01
earningsQuarterlyGrowth
netIncomeToCommon -12.57M
trailingEps -22.92%
forwardEps -5.17%
enterpriseToEbitda -0.49
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.39 3Q 2024
institutionsCount 23
lastUpdated Nov. 6, 2024, 6:26 p.m.